Advertisement

Radionuclide Synovectomy: Treatment of Inflammation of the Synovial Joints

  • F. F. (Russ) Knapp
  • Ashutosh Dash
Chapter

Abstract

Rheumatoid arthritis presents with inflammation of the synovium with resulting chronic pain. For severe cases where aggressive interaction is required, surgical removal/repair of the synovium is practiced. However, in many cases the intra-articular administration of therapeutic radioisotopes attached to particles with the appropriate size and stability characteristics is a simple, inexpensive alternative to counteract the inflammation of the synovium which leads to this chronic pain. In this chapter the types of radioisotopes, the spectrum and types of particles to which they are attached, and the use of these agents for radiation synovectomy (radiosynoviorthesis) are discussed.

Keywords

Dental Fluorosis Inflame Synovium Beta Emitter Synovial Thickness Potassium Sodium Tartrate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Abbasi I, Ishfaq M, Sohaib M. Preparation and pre-clinical study of 177Lu-labelled hydroxyapatite for application in radiation synovectomy of small joints. Q J Nucl Med Mol Imaging. 2011;55:458–68.PubMedGoogle Scholar
  2. Ansell BM, Crook A, Mallard JR, Bywaters EGL. Evaluation of intra-articular colloidal gold Au 198 in the treatment of persistent knee effusions. Ann Rheum Dis. 1963;22:435–9.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Argüelles MG et al. Preparation and evaluation of holmium-166 ferric hydroxide macroaggregates for radiation synovectomy. Alasbimn J. 2003;5:AJ19–9.Google Scholar
  4. Badiavas K, Chatzopoulos D, Markou P. Radiation doses from patients undergoing yttrium-90 silicate knee radiosynovectomy. Hell J Nucl Med. 2006;9:65–8.PubMedGoogle Scholar
  5. Bard DR, Knight CG, Page-Thomas DP. Effect of the intra-articular injection of lutetium-177 in chelator liposomes on the progress of an experimental arthritis in rabbits. Clin Exp Rheumatol. 1985;3:237–42.PubMedGoogle Scholar
  6. Bayly RJ, Peacegood JA, Peake SC. 90Y ferric hydroxide colloid. Ann Rheum Dis. 1973;32:41–2.CrossRefGoogle Scholar
  7. Beer TC, Crawley JC, Farran HE, Gumpel JM. Preliminary assessment of 90Y ferric hydroxide colloid. Ann Rheum Dis. 1973;32:41–2.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Boerbooms AM. Clinical outcome after one year following samarium-153 particulate hydroxyapatite radiation synovectomy. Scand J Rheumatol. 1997;26:136–7.PubMedCrossRefGoogle Scholar
  9. Boerbooms A, Buijs W. Efficacy and safety of radiation synovectomy with Yttrium-90: a retrospective long-term analysis of 164 applications in 82 patients. Br J Rheumatol. 1993;32:1114–5.PubMedCrossRefGoogle Scholar
  10. Bowen BM, Darracott J, Garnett ES, Tomlinson RH. Yttrium-90 citrate colloid for radioisotope synovectomy. Am J Hosp Pharm. 1975;32:1027–30.PubMedGoogle Scholar
  11. Brecelj J, Gmeiner-Stopar T, Jevsek M, et al. Colloidal 90Y used for radiation synovectomy decreases the viability of chondrocytes in human cadaveric samples. Nucl Med Commun. 2007;28:704–10.PubMedCrossRefGoogle Scholar
  12. Calegaro JU, Machado J, De Paula JE, et al. Clinical evaluation after 1 year of 153-samarium hydroxyapatite synovectomy in patients with haemophilic arthropathy. Haemophilia. 2009;15:240–6.PubMedCrossRefGoogle Scholar
  13. Calegaro JU, Machado J, Furtado RG, et al. The use of 185 MBq and 740 MBq of 153-samarium hydroxyapatite for knee synovectomy in haemophilia. Haemophilia. 2014;20:421–5.PubMedPubMedCentralCrossRefGoogle Scholar
  14. Cayla J. Colloidal Au-198 in the treatment of hydrarthrosis in rheumatoid polyarthritis. Rev Rhum Mal Osteoartic. 1967;34:438–41.PubMedGoogle Scholar
  15. Chakraborty S, Das T, Banerjee S, et al. Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints. Nucl Med Commun. 2006;27:661–8.PubMedCrossRefGoogle Scholar
  16. Chakraborty S, Vimalnath KV, Rajeswari A, et al. Preparation, evaluation, and first clinical use of 177Lu-labeled hydroxyapatite (HA) particles in the treatment of rheumatoid arthritis: utility of cold kits for convenient dose formulation at hospital radiopharmacy. J Label Comp Radiopharm. 2014a;57:453–62.CrossRefGoogle Scholar
  17. Chakraborty S, Vimalnath KV, Rajeswari A, et al. Radiolanthanide-labeled HA particles in the treatment of rheumatoid arthritis: ready-to-use cold kits for rapid formulation in hospital radiopharmacy. J Radioanal Nucl Chem. 2014b;302:875–81.CrossRefGoogle Scholar
  18. Chakraborty S, Sharma KS, Rajeswari A, et al. Radiolanthanide-loaded agglomerated Fe3O4 nanoparticles for possible use in the treatment of arthritis: formulation, characterization and evaluation in rats. J Mater Chem B. 2015;3:5455–66.CrossRefGoogle Scholar
  19. Chatzopoulos D, Moralidis E, Markou P, Makris V. Yttrium-90 radiation synovectomy in knee osteoarthritis: a prospective assessment at 6 and 12 months. Nucl Med Commun. 2009;30:472–9.PubMedCrossRefGoogle Scholar
  20. Chinol M, Vallabhajosula S, Zuckerman JD, Goldsmith SJ. In vivo stability of ferric hydroxide macroaggregates (FHMA). Is it a suitable carrier for radionuclides used in synovectomy? Int J Rad Appl Instrum B. 1990;17:479–86.PubMedCrossRefGoogle Scholar
  21. Chinol M, Vallabhajosula S, Goldsmith SJ, et al. Chemistry and biological behavior of samarium- 153 and rhenium- 186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy. J Nucl Med. 1993;34:1536–42.PubMedGoogle Scholar
  22. Cho YJ, Kim KI, Chun YS, et al. Radioisotope synoviorthesis with holmium-166-chitosan complex in haemophilic arthropathy. Haemophilia. 2012;16(4):640–6.Google Scholar
  23. Chrapko B, Zwolak R, Nocuń A, et al. Radiation synovectomy with 90Y colloid in the therapy of recurrent knee joint effusions in patients with inflammatory joint diseases. Rheumatol Int. 2007;27:729–34.PubMedCrossRefGoogle Scholar
  24. Clunie G, Lui D, Cullum I, Ell PJ, et al. Samarium-153-particulate hydroxyapatite radiation synovectomy: biodistribution data for chronic knee synovitis. J Nucl Med. 1995;36:51–7.PubMedGoogle Scholar
  25. Clunie G, Lui D, Cullum I, et al. Clinical outcome after one year following samarium-153 particulate hydroxyapatite radiation synovectomy. Scand J Rheumatol. 1996;25(6):360–6.PubMedCrossRefGoogle Scholar
  26. Davis MA, Chinol M. Radiopharmaceuticals for radiation synovectomy: evaluation of two yttrium-90 particulate agents. J Nucl Med. 1989;30:1047–55.PubMedGoogle Scholar
  27. Dawson TM, Ryan PF, Street AM, et al. Yttrium synovectomy in haemophilic arthropathy. Br J Rheumatol. 1994;33:351–6.PubMedCrossRefGoogle Scholar
  28. Deutsch E, Brodack JW, Deutsch KF. Radiation synovectomy revisited. Eur J Nucl Med. 1993;20:1113–27.PubMedCrossRefGoogle Scholar
  29. Dos Santos MF, Furtado RN, Konai MS, et al. Effectiveness of radiation synovectomy with Yttrium-90 and Samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled, randomized, double-blinded trial. Clin Rheumatol. 2011;30:77–85.PubMedCrossRefGoogle Scholar
  30. Doyle DV, Glass JS, Gow PJ, et al. A clinical and prospective chromosomal study of yttrium-90 synovectomy. Rheumatol Rehabil. 1977;16:217–22.PubMedCrossRefGoogle Scholar
  31. Dunn AL, Busch MT, Wyly JB, Abshire TC. Radionuclide synovectomy for hemophilic arthropathy: a comprehensive review of safety and efficacy and recommendation for a standardized treatment protocol. Thromb Haemost. 2002;87:383–93.PubMedGoogle Scholar
  32. Dunscombe PB, Ramsey NW. Radioactivity studies on two synovial specimens after radiation synovectomy with yttrium-90-silicate. Ann Rheum Dis. 1980;39:87–9.PubMedPubMedCentralCrossRefGoogle Scholar
  33. Dunscombe PB, Bhattacharyya AK, Dale RG. The assessment of the body distribution of yttrium-90 ferric hydroxide during radiation synovectomy. Br J Radiol. 1976;49:372–3.PubMedCrossRefGoogle Scholar
  34. EANM. EANM procedure guidelines for radiosynovectomy. Eur J Nucl Med. 2002;30:BP12–6.Google Scholar
  35. Erselcan T, Bulut O, Bulut S, et al. Lipoma arborescens; successfully treated by yttrium-90 radiosynovectomy. Ann Nucl Med. 2003;17:593–6.PubMedCrossRefGoogle Scholar
  36. Fan Y, Li G, Yao G, Zhang Q, Li G. A study of 153Sm- citrate-hydroxyapatite synovectomy in knee synovitis with rheumatoid arthritis. Chin J Nucl Med. 2006;2:112–4.Google Scholar
  37. Farahati J, Reiners C, Fischer M, et al. Guideline for radiosynorviorthesis. Nuklearmedizin. 1999;38:254–5.PubMedGoogle Scholar
  38. Fellinger K, Schmid J. Die lokale Behandlung der rheumatischen Erkrankungen (Local therapy of rheumatoid arthritis). Wien Z Inn Med. 1952;33:351–63 (In German).PubMedGoogle Scholar
  39. Ferro-Flores G, García-Salinas L, Pedraza-López M, et al. 153Sm metallic-hydroxide macroaggregates: an improved preparation for radiation synovectomy. J Radioanal Nucl Chem. 1997;222:93–7.CrossRefGoogle Scholar
  40. Gedik GK, Uğur O, Atilla B, et al. Comparison of extraarticular leakage values of radiopharmaceuticals used for radionuclide synovectomy. Ann Nucl Med. 2006;20(3):183–8.PubMedCrossRefGoogle Scholar
  41. Göbel D, Gratz S, von Rothkirch T, et al. Radiosynoviorthesis with rhenium-186 in rheumatoid arthritis: a prospective study of three treatment regimens. Rheumatol Int. 1997;17:105–8.PubMedCrossRefGoogle Scholar
  42. Grillenberger KG, Glatz S, Reske SN. Rhenium-188 labeled hydroxyapatite and rhenium-188 sulfur colloid. In vitro comparison of two agents for radiation synovectomy. Nuklearmedizin. 1997;36:71–5.PubMedGoogle Scholar
  43. Gumpel JM. Radiation synovectomy with yttrium-90 silicate. Ann Rheum Dis. 1980;39(6):614–5.PubMedPubMedCentralCrossRefGoogle Scholar
  44. Gumpel JM, Hasp R, Loewi G. Comparison of 90Y ferric hydroxide colloid with the citrate and resin colloids. A preliminary animal study. Ann Rheum Dis. 1973;32:11–2.PubMedPubMedCentralCrossRefGoogle Scholar
  45. Herrick J, Siegal BA, James VL, et al. Hemarthrosis and synovitis associated with hemophilia: clinical use of P-32 chromic phosphate synoviorthesis for treatment. Radiology. 1994;190:257–61.CrossRefGoogle Scholar
  46. Heuft-Dorenbosch LL, de Vet HC, van der Linden S. Yttrium radiosynoviorthesis in the treatment of knee arthritis in rheumatoid arthritis: a systematic review. Ann Rheum Dis. 2000;59:583–6.PubMedPubMedCentralCrossRefGoogle Scholar
  47. Hnatowich DJ, Kramer RI, Sledge CB, et al. Dysprosium-165 ferric hydroxide macroaggregates for radiation synovectomy. J Nucl Med. 1978;19:303–8.PubMedGoogle Scholar
  48. Ishido C. Über die Wirkung des Radiothoriums auf die Gelenke. Strahlentherapie. 1924;15:537–44.Google Scholar
  49. Jacob R, Smith T, Prakasha B, Joannides T. Yttrium90 synovectomy in the management of chronic knee arthritis: a single institution experience. Rheumatol Int. 2003;23:216–20.PubMedCrossRefGoogle Scholar
  50. Jahangier ZN, Jacobs KMG, Bijlsma JWJ, Lafeber FPJG. Radiation synovectomy with yttrium-90 for persisting arthritis has direct harmful effects on human cartilage that cannot be prevented by co-administration of glucocorticoids: an in vitro study. Ann Rheum Dis. 2006;65:1384–9.PubMedPubMedCentralCrossRefGoogle Scholar
  51. Jeong JM, Lee YJ, Kim YJ, Chang YS, et al. Preparation of rhenium-188-tin colloid as a radiation synovectomy agent and comparison with rhenium-188-sulfur colloid. Appl Radiat Isot. 2000;52:851–5.PubMedCrossRefGoogle Scholar
  52. Jia W, Ehrhardt GJ, Zinn K, et al. 186Re/188Re labeled polypeptide microspheres as a potential radiation synovectomy agent. J Radioanal Nucl Chem. 1996;206:107–17.CrossRefGoogle Scholar
  53. Kahan A, Mödder G, Menkes CJ, et al. 169Erbium-citrate synoviorthesis after failure of local corticosteroid injections to treat rheumatoid arthritis-affected finger joints. Clinical Exp Rheumatol. 2004;22:722–6.Google Scholar
  54. Kamaleshwaran KK, Rajamani V, Thirumalaisamy SG, et al. Radiosynovectomy of the elbow joint synovitis in rheumatoid arthritis treated with Lutetium - 177 labeled hydroxylapatite (Lu-177 HA) particulates; first case report and image of Lu -177 HA in the elbow joint. Indian J Nucl Med. 2014;29:270–2.PubMedPubMedCentralCrossRefGoogle Scholar
  55. Kamaleshwaran KK, Rajan D, Krishnan B, et al. Use of yttrium-90 hydroxyapatite radiosynovectomy as a primary modality of treatment in diffuse pigmented villonodular synovitis of the knee joint: a first case report. Indian J Nucl Med. 2015;30:47–50.PubMedPubMedCentralCrossRefGoogle Scholar
  56. Kampen WU, Voth M, Pinkert J, Krause A. Therapeutic status of radiosynoviorthesis of the knee with yttrium-90 (90Y) colloid in rheumatoid arthritis and related indications. Rheumatology. 2007;46:16–24.PubMedCrossRefGoogle Scholar
  57. Karavida N, Notopoulos A. Radiation synovectomy: an effective alternative treatment for inflamed small joints. Hippokratia. 2010;14:22–7.PubMedPubMedCentralGoogle Scholar
  58. Kasteren MEE, Novakava IRO, Boerbooms AMT, Lemmens JAM. Long term follow up of radiosynovectomy with yttrium-90 silicate in haemophilic haemarthrosis. Ann Rheum Dis. 1993;52:548–50.PubMedPubMedCentralCrossRefGoogle Scholar
  59. Kavakli K, Aydogdu S, Taner M, et al. Radioisotope synovectomy with rhenium186 in haemophilic synovitis for elbows, ankles and shoulders. Haemophilia. 2008;14:518–23.PubMedCrossRefGoogle Scholar
  60. Khalid M, Mushtaq A. Preparation and in vitro stability of (n, gamma) yttrium-90 hydroxyapatite. Appl Radiat Isot. 2005;62:587–90.PubMedCrossRefGoogle Scholar
  61. Kitonyi GW, Kitonyi JM. Radiation synovectomy: treatment option for haemophilia patients with chronic haemarthrosis: a review. East Afr Med J. 2009;86:S71–5.PubMedGoogle Scholar
  62. Klett R, Lange U, Haas H, et al. Radiosynoviorthesis of medium-sized joints with rhenium-186-sulfide colloid: a review of the literature. Rheumatology. 2007;46:1531–7.PubMedCrossRefGoogle Scholar
  63. Koca G, Ozsoy H, Atilgan HI, et al. Application of rhenium-186 radiosynovectomy in elbow diffuse pigmented villonodular synovitis – a case report with multiple joint involvement. Nucl Med Mol Imaging. 2012;46:215–7.PubMedPubMedCentralCrossRefGoogle Scholar
  64. Kothari K, Suresh S, Sarma HD, et al. 188Re-labeled hydroxyapatite particles for radiation synovectomy. Appl Radiat Isotopes. 2003;58:463–8.CrossRefGoogle Scholar
  65. Lee SH, Suh JS, Kim HS, et al. MR evaluation of radiation synovectomy of the knee by means of intra-articular injection of holmium-166-chitosan complex in patients with rheumatoid arthritis: results at 4-month follow-up Korean. J Radiol. 2003a;4:170–8.Google Scholar
  66. Lee YJ, Lee YJ, Cheon GJ, et al. 188Re-tin-colloid as a new therapeutic agent for rheumatoid arthritis. Nucl Med Commun. 2003b;24:689–96.PubMedCrossRefGoogle Scholar
  67. Li P, Chen G, Zhang H, Shen Z. Radiation synovectomy by 188Re-sulfide in haemophilic synovitis. Haemophilia. 2004;10(5):422–7.PubMedCrossRefGoogle Scholar
  68. Liepe K, Zaknun JJ, Padhy A, et al. Radiosynovectomy using yttrium-90, phosphorus-32 or rhenium-188 for rheumatoid arthritis of the knee. Ann Nucl Med. 2011;25(5):317–23.PubMedCrossRefGoogle Scholar
  69. Makela OT, Pentilla P, Kolehainen E, et al. Effect of radiosynovectomy with holmium-166 ferric hydroxide macroaggregate on adult equine cartilage. J Rheumatol. 2004;31:321–8.PubMedGoogle Scholar
  70. Manco-Johnson MJ, Nuss R, Lear J, et al. 32P radiosynoviorthesis in children with hemophilia. J Pediatr Hematol Oncol. 2002;24:534–9.PubMedCrossRefGoogle Scholar
  71. Markou P, Chatzopoulos D. Yttrium-90 silicate radiosynovectomy treatment of painful synovitis in knee osteoarthritis. Results after 6 months. Hell J Nucl Med. 2009;12:33–6.PubMedGoogle Scholar
  72. McLaren A, Hetherington E, Maddalena D, Snowdon G. Dysprosium (165Dy) hydroxide macroaggregate for radiation synovectomy animal studies. Eur J Nucl Med. 1990;16:626–32.CrossRefGoogle Scholar
  73. Menkes CJ, Gô AL, Verrier P, et al. Double-blind study of erbium 169 injection (synoviorthesis) in rheumatoid digital joints. Ann Rheum Dis. 1977;36:254–6.PubMedPubMedCentralCrossRefGoogle Scholar
  74. Mödder G. Radiosynoviorthesis. Involvement of nuclear medicine in rheumatology and orthopaedics. Meckenheim: Warlich Druck und Verlagsges GmbH; 1995.Google Scholar
  75. Mortazavi SMJ, Asadollahi S, Farzan M, et al. 32P colloid radiosynovectomy in treatment of chronic haemophilic synovitis: Iran experience. Haemophilia. 2007;13:182–8.PubMedCrossRefGoogle Scholar
  76. Moskowitz RW. Osteoarthritis: diagnosis and medical/surgical management. Baltimore: Lippincott Williams & Wilkins; 2007.Google Scholar
  77. Mupmer RJ, Mills BJA, Ryo UY, Jay M. Polymeric microspheres for radionuclide synovectomy containing neutron-activated holmium-166. J Nucl Med. 1992;33:398–402.Google Scholar
  78. O’Doherty J, Clauss R, Scuffham J, et al. Three dosimetry models of lipoma arborescens treated by 90Y synovectomy. Med Phys. 2014a;41:052501.PubMedCrossRefGoogle Scholar
  79. O’Doherty J, Clauss R, Scuffham J, Khan A. Lipoma arborescens successfully treated with (90)Y synovectomy. Clin Nucl Med. 2014b;39:e187–9.PubMedGoogle Scholar
  80. O’Duffy EK, Clunie GP, Lui D, et al. Double blind glucocorticoid controlled trial of samarium-153 particulate hydroxyapatite radiation synovectomy for chronic knee synovitis. Ann Rheum Dis. 1999a;58:554–8.PubMedPubMedCentralCrossRefGoogle Scholar
  81. O’Duffy EK, Oliver FJ, Chatters SJ, et al. Chromosomal analysis of peripheral lymphocytes of patients before and after radiation synovectomy with samarium-153 particulate hydroxyapatite. Rheumatology (Oxford). 1999b;38:316–22.CrossRefGoogle Scholar
  82. Ofluoglu S, Schwameis E, Zehetgruber H, et al. Radiation synovectomy with 166Ho-ferric hydroxide: a first experience. J Nucl Med. 2002;43:1489–94.PubMedGoogle Scholar
  83. Oka M. Radiation synovectomy of the rheumatoid knee with yttrium 90. Ann Clin Res. 1975;7:205–10.PubMedGoogle Scholar
  84. Oka M, Rekonen A, Rvotsi A, Seppala O. Intra articular injection of Y-90-resin colloid in the treatment of rheumatoid knee joint effusions. Acta Rheumatol Scand. 1971;17:148–60.PubMedCrossRefGoogle Scholar
  85. Onetti CM, Gutierrez E, Hliba E, Aguirre CR. Synoviorthesis with 32P-colloidal chromic phosphate in rheumatoid arthritis – clinical, histopathologic and arthrographic changes. J Rheumatol. 1982;9:229–38.PubMedGoogle Scholar
  86. Otero M, Goldring MB. Cells of the synovium in rheumatoid arthritis: chondrocytes. Arthritis Res Ther. 2007;9:220.PubMedPubMedCentralCrossRefGoogle Scholar
  87. Özcan Z. Radiosynovectomy in hemophilic synovitis. Mol Imaging Radionucl Ther. 2014;23:1–4.PubMedPubMedCentralCrossRefGoogle Scholar
  88. Oztemür Z, Bulut O, Korkmaz M, et al. Surgical synovectomy combined with yttrium 90 in patients with recurrent joint synovitis. Rheumatol Int. 2013;33:1321–6.PubMedCrossRefGoogle Scholar
  89. Pandey U, Mukherjee A, Chaudhary PR, et al. Preparation and studies with 90Y-labelled particles for use in radiation synovectomy. Appl Radiat Isot. 2001;55:471–5.PubMedCrossRefGoogle Scholar
  90. Pavelka K, Meier-Ruge W, Müller W, Fridrich R. Histological study of effects of colloidal 90yttrium on knee joint tissues of rabbits. Ann Rheum Dis. 1975;34:64–9.PubMedPubMedCentralCrossRefGoogle Scholar
  91. Prabhakar G, Sachdev SS, Umamaheswari S, et al. Development of samarium [32P] phosphate colloid for radiosynoviorthesis applications: preparation, biological and preliminary clinical studies experience. Appl Radiat Isot. 2007;65(12):1309–13.PubMedCrossRefGoogle Scholar
  92. Rivard GE, Girard M, Lamarre C, et al. Synoviorthesis with colloidal 32P chromic phosphate for hemophilic arthropathy: clinical follow-up. Arch Phys Med Rehabil. 1985;66:753–6.PubMedGoogle Scholar
  93. Rivard GE, Girard M, Belanger R, et al. Synoviorthesis with colloidal 32P chromic phosphate for the treatment of hemophilic arthropathy. J Bone Joint Surg Am. 1994;76:482–8.PubMedGoogle Scholar
  94. Santos MF, Furtado RN, Konai MS, et al. Effectiveness of radiation synovectomy with samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled randomized double-blind trial. Clinics (Sao Paulo). 2009;64:1187–93.CrossRefGoogle Scholar
  95. Schmid E, Selbach HJ, Voth M, et al. The effect of the beta-emitting yttrium-90 citrate on the dose-response of dicentric chromosomes in human lymphocytes: a basis for biological dosimetry after radiosynoviorthesis. Radiat Environ Biophys. 2006;45:93–8.PubMedCrossRefGoogle Scholar
  96. Schneider P, Farahati J, Reiners C. Radiosynovectomy in rheumatology, orthopedics, and hemophilia. J Nucl Med. 2005;46:48S–54.PubMedGoogle Scholar
  97. Seong SK, Ryu JM, Shin DH, Bae EJ, Shigematsu A, Hatori Y, Nishigaki J, Kwak C, Lee SE, Park KB. Biodistribution and excretion of radioactivity after the administration of 166Ho-chitosan complex (DW-166HC) into the prostate of rat. Eur J Nucl Med Mol Imaging. 2005;32:910–7.Google Scholar
  98. Shabat S, Kollender Y, Merimsky O, et al. The use of surgery and yttrium 90 in the management of extensive and diffuse pigmented villonodular synovitis of large joints. Rheumatology (Oxford). 2002;41:1113–8.CrossRefGoogle Scholar
  99. Shamim SA, Kumar R, Halanaik D, et al. Role of rhenium-188 tin colloid radiosynovectomy in patients with inflammatory knee joint conditions refractory to conventional therapy. Nucl Med Commun. 2010;31:814–20.PubMedCrossRefGoogle Scholar
  100. Shin BC, Park KB, Jang BS, et al. Preparation of 153Sm-chitosan complex for radiation synovectomy. Nucl Med Biol. 2001;28:719–25.PubMedCrossRefGoogle Scholar
  101. Shin CY, Son M, Ko JI, et al. DA-7911, 188Rhenium-tin colloid, as a new therapeutic agent of rheumatoid arthritis. Arch Pharm Res. 2003;26:168–72.PubMedCrossRefGoogle Scholar
  102. Shin K, Lee JC, Choi HJ, et al. Radiation synovectomy using 188Re-tin colloid improves knee synovitis as shown by MRI in refractory rheumatoid arthritis. Nucl Med Commun. 2007;28:239–44.PubMedCrossRefGoogle Scholar
  103. Shukla J, Bandhopadhyaya GP, Shamim SA, Kumar R. Characterization of Re-188-Sn-microsperes used for synovitis treatment. Int J Pharmaceutics. 2007;338:43–7.CrossRefGoogle Scholar
  104. Siegel HJ, Luck JV, Siegel ME, Quines C, Anderson E. Hemarthrosis and synovitis associated with hemophilia: clinical use of 32P chromic phosphate synoviorthesis for treatment. Radiology. 1994;190:257–61.PubMedCrossRefGoogle Scholar
  105. Siegel HJ, Luck Jr JV, Siegel ME, Quinones C. Phosphate-32 colloid radiosynovectomy in hemophilia: outcome of 125 procedures. Clin Orthop. 2001;392:409–17.PubMedCrossRefGoogle Scholar
  106. Silva M, Luck JVJ, Siegel ME. 32P chromic phosphate radiosynovectomy for chronic haemophilic synovitis. Haemophilia. 2001;7:40–9.PubMedCrossRefGoogle Scholar
  107. Sledge CB, Zuckerman JD, Zalutsky MR, Atcher RW, Shortkroff S, Lionberger DR, Rose HA, Hurson BJ, Lankenner PA Jr, Anderson RJ, et al. Treatment of rheumatoid synovitis of the knee with intraarticular injection of dysprosium 165-ferric hydroxide macroaggregates. Arthritis Rheum. 1986;29:153–9.Google Scholar
  108. Sohaib M, Abbasi I, Ishfaq M. In vivo evaluation of Lu-177 hydroxyapatite for application in radiation synovectomy of digital joints. J Nucl Med. 2011;52(Suppl):1384.Google Scholar
  109. Song J, Suh CH, Park YB, et al. A phase I/IIa study on intra-articular injection of holmium-166-chitosan complex for the treatment of knee synovitis of rheumatoid arthritis. Eur J Nucl Med. 2001;28(4):489–97.PubMedCrossRefGoogle Scholar
  110. Spooren P, Johannes J, Rasker JJ. Synovectomy of the knee with 90Y. Eur J Nucl Med. 1985;10:441–5.PubMedGoogle Scholar
  111. Stucki G, Bozzone P, Treuer E, et al. Efficacy and safety of radiation synovectomy with yttrium-90: a retrospective long-term analysis of 164 applications in 82 patients. Br J Rheumatol. 1993;32:383–6.PubMedCrossRefGoogle Scholar
  112. Taylor WJ, Corkill MM, Rajapaske CN. A retrospective review of yttrium-90 synovectomy in the treatment of knee arthritis. Br J Rheumatol. 1997;36:1100–5.PubMedCrossRefGoogle Scholar
  113. Tebib JG, Manil LM, Mödder G, et al. Better results with rhenium-186 radiosynoviorthesis than with cortivazol in rheumatoid arthritis(RA): a two-year follow-up randomized controlled multicentre study. Clin Exp Rheumatol. 2004;22:609–16.PubMedGoogle Scholar
  114. Teyssler P, Taborska K, Kolostova K, Bobek V. Radiosynoviorthesis in hemophilic joints with yttrium-90 citrate and rhenium-186 sulfide and long term results. Hell J Nucl Med. 2013;16:44–9.Google Scholar
  115. Thomas S, Gabriel MB, Assi PE, et al. Radioactive synovectomy with 90Y- citrate in haemophilic synovitis: Brazilian experience. Brazilian Hemophilia Centers. Haemophilia. 2011a;17:e211–6.PubMedCrossRefGoogle Scholar
  116. Thomas S, Gabriel MC, de Souza SA, et al. A 90Yttrium-hydroxyapatite: a new therapeutic option for radioactive synovectomy in haemophilic synovitis. Haemophilia. 2011b;17:e985–9.PubMedCrossRefGoogle Scholar
  117. Topp JR, Cross EG. The treatment of persistent knee effusions with intra-articular radioactive gold: preliminary report. Can Med Assoc J. 1970;102:709–14.PubMedPubMedCentralGoogle Scholar
  118. Torres M, Ayra E, Albuerne O, Montana Delgado MA. Adsorbed does profiles for 32P, 90Y, 188Re, 153Sm and 169Er: radionuclides used for radiosynoviorthese treatment. Rev Esp Med Nul. 2009;28(4):188–92.CrossRefGoogle Scholar
  119. Turkmen C, Ozturk S, Unal SN, et al. The genotoxic effects in lymphocyte cultures of children treated with radiosynovectomy by using yttrium-90 citrate colloid. Cancer Biother Radiopharm. 2007;22:393–9.PubMedCrossRefGoogle Scholar
  120. Unni PR, Chaudari PR, Venkatesh M, et al. Preparation and bioevaluation of 166Ho labeled hydroxyapatite (HA) particles for radiosynovectomy. Nucl Med Biol. 2002;29:199–209.PubMedCrossRefGoogle Scholar
  121. Ures MC, Savio E, Malanga A, et al. Physico-chemical characterisation and biological evaluation of 188-Rhenium colloids for radiosynovectomy. BMC Nucl Med. 2002;2:1–9.PubMedPubMedCentralCrossRefGoogle Scholar
  122. Van der Zant FW. Radiation synovectomy of the ankle, knee and upper extremity joints. Proefschrift. The Netherlands: Marcelis Vanderlee-ADU-BV; 2008. ISBN 9789039349281.Google Scholar
  123. Van der Zant FM, Jahangier ZN, Moolenburgh JD, et al. Radiation synovectomy of the ankle with 75 MBq colloidal 186Rhenium-sulfide: effect, leakage, and radiation considerations. J Rheumatol. 2004;31:896–901.PubMedGoogle Scholar
  124. Van der Zant FM, Boer RO, Moolenburgh JD, et al. Radiation synovectomy with (90)Yttrium, (186)Rhenium and (169)Erbium: a systematic literature review with meta-analyses. Clin Exp Rheumatol. 2009;27:130–9.PubMedGoogle Scholar
  125. Van Soesbergen RM, Hoefnagel CA, Marcuse HR, et al. Radiosynoviorthesis of the knee: a doubleblind trial of 1 versus 5 mCi Gold-198. Clin Rheumatol. 1988;7:224–30.PubMedCrossRefGoogle Scholar
  126. Vimalnath KV, Chakraborty S, Rajeswari A, et al. Radiochemistry, pre-clinical studies and first clinical investigation of 90Y-labeled hydroxyapatite (HA) particles prepared utilizing 90Y produced by (n, γ) route. Nucl Med Biol. 2015;42:455–64.PubMedCrossRefGoogle Scholar
  127. Visuthikosol V, Kumpolpunth S. Intra-articular radioactive colloidal gold (198 Au) in the treatment of rheumatoid arthritis. J Med Assoc Thai. 1981;64:419–27.PubMedGoogle Scholar
  128. Voth M, Klett R, Lengsfeld P, Stephan G, Schmid E. Biological dosimetry after yttrium-90 citrate colloid radiosynoviorthesis. Nuklearmedizin. 2006;45:223–8.PubMedGoogle Scholar
  129. Wang SJ, Lin WY, Hsieh BT, et al. Rhenium-188 sulphur colloid as a radiation synovectomy agent. Eur J Nucl Med. 1995;22:505–7.PubMedCrossRefGoogle Scholar
  130. Wang SJ, Lin WY, Chen MN, et al. Histologic study of effects of radiation synovectomy with rhenium-188 microspheres. Nucl Med Biol. 2001;28:727–32.PubMedCrossRefGoogle Scholar
  131. Will R, Laing B, Edelman J, Lovegrove F, Surveyor I. Comparison of two yttrium-90 regimens in inflammatory and osteoarhtropathies. Ann Rheum Dis. 1992;51:262–5.PubMedPubMedCentralCrossRefGoogle Scholar
  132. Wiss DA. Recurrent villonodular synovitis of the knee. Successful treatment with yttrium-90. Clin Orthop Relat Res. 1982;169:139–44.PubMedGoogle Scholar
  133. Wong Y, Cherk MH, Powell A, et al. Efficacy of yttrium-90 synovectomy across a spectrum of arthropathies in an era of improved disease modifying drugs and treatment protocols. Int J Rheum Dis. 2014;17(1):78–83.PubMedCrossRefGoogle Scholar
  134. Wunderlich G, Pinkert J, Andreeff M, et al. Preparation and biodistribution of rhenium-188 labeled albumin microspheres B 20: a promising new agent for radiotherapy. Appl Radiat Isot. 2000;52:63–8.PubMedCrossRefGoogle Scholar
  135. Wunderlich G, Drews A, Kotzerke J. A kit for labeling of [188Re] human serum albumin microspheres for therapeutic use in nuclear medicine. Appl Radiat Isot. 2005;62:915–8.PubMedCrossRefGoogle Scholar
  136. Yarbrough TB, Lee MR, Hornof WJ, et al. Samarium 153-labeled hydroxyapatite microspheres for radiation synovectomy in the horse: a study of the biokinetics, dosimetry, clinical, and morphologic response in normal metacarpophalangeal and metatarsophalangeal joints. Vet Surg. 2000;29:191–9.PubMedCrossRefGoogle Scholar
  137. Yu J, Häfeli UO, Xia J, et al. Radiolabelling of poly(histidine) derivatized biodegradable microspheres with the 188Re tricarbonyl complex [188Re(CO)3(H2O)3]+. Nucl Med Comm. 2005;26:453–8.CrossRefGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  • F. F. (Russ) Knapp
    • 1
  • Ashutosh Dash
    • 2
  1. 1.Nuclear Security and Isotope DivisionOak Ridge National LaboratoryOAK RIDGEUSA
  2. 2.Isotope Production and Applications DivisionBhabha Atomic Research CentreMumbaiIndia

Personalised recommendations